Cargando…
Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen
Thrombocytopenia is the most common cause of bleeding tendency, and, if due to impaired platelet production, is best treated by platelet transfusions. Prophylactic transfusions for asymptomatic patients should be considered if platelet count is below 20000/μl. However, if bleeding occurs or surgery...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095859/ https://www.ncbi.nlm.nih.gov/pubmed/1921239 http://dx.doi.org/10.1007/BF01647409 |
_version_ | 1783510699399446528 |
---|---|
author | Söhngen, D. Schneider, W. |
author_facet | Söhngen, D. Schneider, W. |
author_sort | Söhngen, D. |
collection | PubMed |
description | Thrombocytopenia is the most common cause of bleeding tendency, and, if due to impaired platelet production, is best treated by platelet transfusions. Prophylactic transfusions for asymptomatic patients should be considered if platelet count is below 20000/μl. However, if bleeding occurs or surgery is inevitable, platelet count should be maintained above 50000/μl. The benefit of platelet transfusions has to be balanced against risks like fever, infections and haemolysis. The effectiveness of platelet transfusions should be examined after 1 and 24 hrs by measuring the corrected count increment (CCI). Not only alloimmunization is a reason for unsatisfactory platelet increments. A poor CCI can also be due to fever, sepsis, hepato-splenomegaly or special drugs, which must be taken into account when assessing the demand for platelet transfusions. |
format | Online Article Text |
id | pubmed-7095859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70958592020-03-26 Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen Söhngen, D. Schneider, W. Klin Wochenschr Übersicht Thrombocytopenia is the most common cause of bleeding tendency, and, if due to impaired platelet production, is best treated by platelet transfusions. Prophylactic transfusions for asymptomatic patients should be considered if platelet count is below 20000/μl. However, if bleeding occurs or surgery is inevitable, platelet count should be maintained above 50000/μl. The benefit of platelet transfusions has to be balanced against risks like fever, infections and haemolysis. The effectiveness of platelet transfusions should be examined after 1 and 24 hrs by measuring the corrected count increment (CCI). Not only alloimmunization is a reason for unsatisfactory platelet increments. A poor CCI can also be due to fever, sepsis, hepato-splenomegaly or special drugs, which must be taken into account when assessing the demand for platelet transfusions. Springer-Verlag 1991 /pmc/articles/PMC7095859/ /pubmed/1921239 http://dx.doi.org/10.1007/BF01647409 Text en © Springer-Verlag 1991 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Übersicht Söhngen, D. Schneider, W. Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen |
title | Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen |
title_full | Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen |
title_fullStr | Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen |
title_full_unstemmed | Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen |
title_short | Thrombozytentransfusion: Klinik, Kontrollen und Komplikationen |
title_sort | thrombozytentransfusion: klinik, kontrollen und komplikationen |
topic | Übersicht |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095859/ https://www.ncbi.nlm.nih.gov/pubmed/1921239 http://dx.doi.org/10.1007/BF01647409 |
work_keys_str_mv | AT sohngend thrombozytentransfusionklinikkontrollenundkomplikationen AT schneiderw thrombozytentransfusionklinikkontrollenundkomplikationen |